BioInfra Life Science Inc. (XKON:266470)
South Korea
· Delayed Price · Currency is KRW 160.00
-21.00 (-11.60%)
At close: Mar 9, 2026
BioInfra Life Science Company Description
BioInfra Life Science Inc., a healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea.
It provides cancer screening test technology service, cancer biomarker research, in-vitro diagnostics medical devices, and targeted drug delivery systems for cancer treatment.
The company was founded in 2001 and is headquartered in Seoul, South Korea.
BioInfra Life Science Inc.
| Country | South Korea |
| Founded | 2001 |
| Industry | Surgical and Medical Instruments and Apparatus |
| CEO | Dukyun Lee |
Contact Details
Address: 66, 1st Building Seoul South Korea | |
| Phone | 82 2 6271 0102 |
| Website | bioinfra.co.kr |
Stock Details
| Ticker Symbol | 266470 |
| Exchange | Korea New Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dukyun Lee | Chief Executive Officer |